Richards Jessika, Wascher Molly, Alwan Michael, Beardsley James, Naseman Ryan, Nesbit Todd, Trujillo Tate, Fuller Patrick
Ascension St. John Hospital, Detroit, MI, USA.
The Johns Hopkins Hospital, Baltimore, MD, USA.
Hosp Pharm. 2019 Dec;54(6):365-370. doi: 10.1177/0018578718802831. Epub 2018 Sep 22.
The process of privileging pharmacists is an important step in developing optimal pharmacy practice models. Currently, little published literature exists detailing the status of pharmacist privileging efforts. The objective of this study is to assess and characterize a snapshot of the current and future state of privileging practices in pharmacy at Vizient academic medical centers (AMCs) and their affiliate institutions. An electronic survey questionnaire was sent to Vizient pharmacy directors and their affiliates to assess institutional privileging practices and identify perceived or actual barriers. The survey was divided into 2 pathways based on the current status of privileging at the institution. In total, 46 directors of pharmacy completed the survey. Only 33% (15/46) of pharmacy directors indicated they had a current privileging process in place. About 70% (21/30) of institutions without an established privileging process indicated they were considering establishing a process. For institutions without an established privileging process, most pharmacy directors identified a lack of organizational support and resources as barriers to implementation. Although credentialing and privileging is considered a national priority to aid in expanding and enhancing pharmacists' scope of practice, our survey demonstrated that few respondents currently have a privileging process in place. The results from this study may highlight important barriers and keys to success to be considered when implementing a privileging process.
赋予药剂师特权的过程是发展最佳药学实践模式的重要一步。目前,鲜有已发表的文献详细阐述药剂师特权授予工作的现状。本研究的目的是评估并描述Vizient学术医疗中心(AMC)及其附属机构当前和未来药学特权授予实践的状况。向Vizient药房主任及其附属机构发送了一份电子调查问卷,以评估机构的特权授予实践并识别感知到的或实际存在的障碍。根据机构特权授予的现状,调查分为两条路径。共有46位药房主任完成了调查。只有33%(15/46)的药房主任表示他们目前有特权授予流程。在没有既定特权授予流程的机构中,约70%(21/30)表示他们正在考虑建立一个流程。对于没有既定特权授予流程的机构,大多数药房主任认为缺乏组织支持和资源是实施的障碍。尽管认证和特权授予被视为国家优先事项,以帮助扩大和增强药剂师的实践范围,但我们的调查表明,目前很少有受访者有特权授予流程。本研究的结果可能突出了实施特权授予流程时需要考虑的重要障碍和成功关键。